Richard J. Maguire
AcceptedAbstracts: Transl Med
To deliver personalized medicine requires the convergence of many complex factors that are challenging the health science industry � availability of high quality patient data, integration of data silos, combining clinical and Omics data, the impact of Next Generation Sequencing and bridging the gap between research and clinical decision-making. Collaboration is at the heart of all these challenges because without it new discoveries and better understanding of disease can�t be made, let alone shared and implemented. The entire health science ecosystem, which includes academic medical centers, pharmaceutical and diagnostic companies, hospitals and payers; needs to work together to share translational medicine data in multiple ways to support drug discovery, diagnostic development and comparative effectiveness research. This presentation will look at these challenges and provide real world examples of how research and clinical teams are working together to make personalized medicine a reality.
Richard Maguire has two Ph.D.?s from MIT ? Ion Physics and Chemical Biology care of the US Navy. Previously, he was the Director of Translational Research Program Management at Roswell Park Cancer Institute in Buffalo, NY. He was also the Co-Director of the Proteomics Core. He joined IDBS in May of 2011 as Principal Analyst, Translational Medicine and his role is to act as the domain subject matter expert for Translational Medicine in North America. He is a Subject Matter Expert on Translational Research & Medicine especially within the context of Oncology, Medical Informatics, Research Informatics, Biobanks and Ontologies as it pertains to research and clinical applications.
